Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

Advanced Methods in Renal MRI

Back to the Program-at-a-Glance

Advanced Methods in Renal MRI
Digital Poster
Body
Monday, 11 May 2026
Digital Posters Row H
17:05 - 18:00
Session Number: 367-06
No CME/CE Credit
The session includes presentations summarizing the latest developments and advances in renal MRI.
Skill Level: Intermediate

  Figure 367-06-001.  Evaluation of Asiatic Acid Efficacy and Development of a Multiparametric MRI-Based Grading Model for Renal Fibrosis in Rats
xueting wang, Lihua Chen, Yujun Lu, Weijing Yan, Shuangshuang Xie, Jipan Xu, Guoxiang Wang, Chen Zhang, Jinxia ZHU, Bernd Kuehn, Shen Wen
Nankai University, Tianjin, China
Impact: Multi-parametric MRI evaluates the efficacy, enabling accurate longitudinal monitoring of treatment response. It facilitates the development of a machine learning model for precise fibrosis staging, addressing the need for repeated invasive biopsies and providing a basis for improved patient management.
  Figure 367-06-002.  Noninvasive Detection of Early Stage Renal Fibrosis Associated with Microcysts in Polycystic Kidney Disease by Precision MRI
Oluwabukola Bamishaye, Francis Akinlotan, Phillip Chumley, Jingjuan Qiao, Roye Ronald, Anita Dorabadizare, Khan Hekmatyar, Xiu Chen, Annye Bennet, Anna Sorace, Alton Farris, Harrison Kim, Jian-xiong Wang, Michal Mrug, Jenny Yang
Georgia State University, Atlanta, United States of America
Impact: This transformative contrast will be the first time enable a non-invasive rapid monitoring of pro-fibrotic disease activity and response to therapeutics for ADPKD, expediting and reducing the cost of drug development and allowing effective monitoring of drugs during clinical practice.
  Figure 367-06-003.  Application of Renal Pseudo-Continuous Arterial Spin Labeling Radiomics in Early Diagnosis and Staging of Chronic Kidney Dise
Haiyun Xu, Wei Mao, Fang Lu, Caixia Fu, Bernd Kuehn, Guang Yang, Shuohui Yang
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Impact: The combined model of pCASL-derived renal blood flow and clinical variables significantly enhances accuracy in early CKD diagnosis and staging, aiding clinical practice.
  Figure 367-06-004.  ASL and T1-mapping to Assess Renal Function at Different Stages of Early Graft Dysfunction after Renal Transplantation
Jiali Ma, Chenqin Que, Jiayi Wan, Peng Wu, Mo Zhu
The First Affiliated Hospital of Soochow University, Suzhou, China
Impact: This study provides clinicians with a robust, non-invasive multiparametric MRI model for precise early graft dysfunction diagnosis, enabling dynamic monitoring and potential early intervention, which may ultimately improve patient prognosis.
  Figure 367-06-005.  Multiparametric Renal MRI in Lupus Nephritis: Qualitative Classification and Quantitative Analysis Across Disease States
Xiaoxiao Zhang, Gumuyang Zhang, Hao Sun, can huang, Jinxia ZHU
Impact: Multiparametric renal MRI provides a noninvasive means to detect residual renal injury and monitor disease activity in lupus nephritis. It enables imaging-based disease stratification beyond conventional remission criteria, potentially improving therapeutic guidance and long-term renal outcome prediction.
  Figure 367-06-006.  Choice of IVIM-DWI fitting substantially impacts parameter estimation in multi-center renal studies
Siria Pasini, Rebeca Echeverria-Chasco, Leyre Garcia-Ruiz, Steffen Ringgaard, Oliver Gurney-Champion, Ivan Rashid, Anika Strittmatter, GIULIA VILLA, Anish Raj, Ioana Urdea, Susan Francis, Christoffer Laustsen, Frank Zoellner, Maria Fernandez-Seara, Anna Caroli
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica (BG), Italy
Impact: Renal IVIM-DWI parameter estimates depend strongly on fitting algorithm, with different best-performing algorithms across sites, despite protocol standardization. Reliable algorithm selection and site-specific performance assessment are essential for reproducible multi-center studies and quantitative renal imaging clinical translation.
  Figure 367-06-007.  Pathology-Validated Radiomics Models Based on Diffusion Tensor Imaging for Assessing Renal Allograft Fibrosis
Jiali Ma, Junjie Yang, Peng Wu, Chenqin Que, Mo Zhu
The First Affiliated Hospital of Soochow University, Suzhou, China
Impact: This study enables non-invasive, accurate fibrosis assessment in renal transplants using DTI-radiomics, potentially reducing biopsy needs. It validates medullary FA as a key biomarker, facilitating early intervention and improved patient monitoring.
  Figure 367-06-008.  Standardized Multi-Vendor Acquisition Protocol for Whole-Body Quantitative Dixon MRI of Muscle
Ananya Goyal, Martijn Froeling, Valentina Mazzoli, Feliks Kogan, Linda Heskamp, Evert Onno WEsselink, Merve Kaptan, Garry Gold, Scott Delp, Marnee McKay, James Elliott, Benjamin De Leener, Julien Cohen-Adad, Christine S W Law, Daniel Nanz, Kenneth Weber
Stanford University, Stanford, United States of America
Impact: 
This study establishes a standardized whole-body Dixon MRI protocol for consistent, high-resolution muscle imaging across scanners and sites, enabling large-scale, shareable datasets that accelerate AI-based segmentation, quantitative biomarker development, and multi-center research in musculoskeletal and neuromuscular health.
  Figure 367-06-009.  Assessment of Renal and Hepatic Relaxation Times of Deuterium (²H) Labeled Resonances at 7T
Viola Bader, Bernhard Strasser, Lukas Hingerl, Johannes Kovarik, Sabina Frese, Lorenz Pfleger, Anna Duguid, Aaron Osburg, Hauke Fischer, Martin Krssak, Thomas Scherer, Pascal Baltzer, Wolfgang Bogner, Fabian Niess
Medical University of Vienna, Vienna, Austria
Impact: Knowledge of organ-specific ²H relaxation constants increases the accuracy of concentration estimation and can therefore improve the understanding of underlying metabolic processes in renal and hepatic physiology and pathology, which potentially pushes abdominal DMI closer towards clinical application.
  Figure 367-06-010.  Deuterium MRI for the Evaluation of Treatment Response in Solid Tumors: Pseudo-progression vs Progression
Mingchen He, Jill Duzen, Hunter Reavis, Steven Turowski, Joseph Spernyak, Michael Feigin, Aimee Stablewski, Ravi Jasuja, Nataliya Buxbaum
Roswell Park Comprehensive Cancer Center, Buffalo, United States of America
Impact: Pseudo-progression negatively impacts cancer patients. It can lead to premature discontinuation of effective and potentially curative therapies. Pseudo-progression also delays drug development. Our clinically relevant approach allows differentiation of tumor pseudo-progression from worsening disease addressing a key gap in oncology.
  Figure 367-06-011.  MRI in Clinical Practice: Detection of a subcentimetric rare renal tumor not visualized on CT Angiography
Nader Gharbia, Yasmine Saad, Kays Cheker, Wasim Frikha, Yassine Nouira
Faculty of medicine of Sfax, Tunisia
Impact: MRI detected a Subcentimetric rare renin-secreting tumor missed on CT angiography, guiding nephron-sparing surgery and enabling resolution of severe refractory hypertension, highlighting MRI’s pivotal role in detecting small renal lesions in clinical practice.
  Figure 367-06-012.  Evaluation of renal perfusion and oxygenation in patients with hypertension and chronic kidney disease at 5T
Weihuan Fang, Mingyan Wu, Guili Chang, Xin Chen, Junqi Xu, Yiling Liu, Jiekai Zhu, Jiawen Sun, Chen Chen, Xingfeng Shao, Fuhua Yan
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Impact: 5T ASL is a clinically reliable approach in evaluating hypertensive renal dysfunction
  Figure 367-06-013.  Microstructural Differentiation of Solid Renal Masses Using Time-Dependent Diffusion MRI
WEI WANG, Zhongxu Bi, Jingyun Wu, Jianxing Qiu, jianxiu lian, xiaoxiao zhang
Peking University First Hospital, Beijing, China
Impact: Time-dependent diffusion MRI quantifies tumor cellularity and cell diameter, enhancing preoperative differentiation of renal masses. This non-invasive method may avoid the risk of biopsies and guide personalized treatment decisions.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine